TD-1211
0074
Phase 2 small_molecule completed
Quick answer
TD-1211 for Opioid-induced Constipation (OIC) is a Phase 2 program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Opioid-induced Constipation (OIC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed